生物制药管道市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPRE00008648
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Biopharmaceutical Tubing Market Size and CAGR by 2031

Buy Now

生物制药导管市场规模预计将从 2023 年的 40.4 亿美元增至 2031 年的 76.4 亿美元。预计 2023-2031 年期间市场复合年增长率将达到8.30%。铂固化硅胶作为生物制药导管的首选材料可能仍将是市场的主要趋势。

 生物制药管道市场分析

生物制药导管市场已经很成熟。然而,由于人们越来越关注更好的手术结果和相关条件,预计该市场将增长更快。推动市场扩张的主要因素是微创手术数量的增加以及该领域对使用导管的医疗器械的需求急剧增加。

据估计,生物制药管材市场有望成为亚洲增长最快的市场。人口老龄化、药品以及价格合理的医用级塑料的供应将大大提升盈利前景。

生物制药管道市场概况

预期寿命的增加导致全球老年人口增加。世界卫生组织 (WHO) 预测,到 2050 年,全球 60 岁以上成年人的比例将几乎翻一番,从 2015 年的 12% 增至 22%。联合国的《2017 年世界人口老龄化报告》指出,2017 年全球 60 岁以上成年人口为 9.62 亿。预计到 2050 年,这一数字将上升至约 21 亿。此外,美国人口普查局预测,到 2060 年,美国 65 岁以上人口将从 2016 年的 4600 万增加到 9800 多万,其人口比例将从约 15% 增至约 24%。根据联合国 2017 年世界人口老龄化报告,欧洲 60 岁以上成年人口的比例最高(25%)。由于全球老龄化加速,到 2050 年,除非洲以外,世界各地区相当一部分人口将达到 60 岁或以上。到 2030 年、2050 年和 2100 年,全球老年人口预计将分别达到 14 亿美元、21 亿美元和 31 亿美元以上。人口老龄化导致老年病增多,进而推动对药物输送系统和诊断工具的需求。

此外,这也导致需要导尿的泌尿系统疾病的患病率上升。此外,医生正在推动自我导尿,以减少住院时间和费用,同时降低医疗相关感染 ( HAI )的风险。导致可能需要ICU干预的慢性病增加的一个关键因素是老龄化。因此,老年人口的快速增长推动了生物制药管道系统的采用,这与对包含管道、药物输送、透析、心脏搭桥、蠕动泵和无菌灌装和分配系统的医疗设备的需求不断增长直接相关。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

生物制药管道市场:

生物制药管道市场
  • Biopharmaceutical Tubing Market
    复合年增长率(2023 - 2031)
    8.30%
  • 2023 年市场规模
    40.4 亿美元
  • 2031 年市场规模
    76.4 亿美元

市场动态

增长动力
  • 微创手术需求不断增长
未来趋势
  • 使用铂固化硅胶作为生物制药管材的首选材料
机会
  • 发展中国家医疗保健行业的扩张和慢性病患病率的上升

关键人物

  • 戈尔公司及其合伙人
  • 圣戈班安全材料
  • 科德宝集团
  • 瑞士劳美迪克公司
  • 技术综合公司
  • 新时代工业有限公司
  • 奥普蒂诺娃
  • 宙斯工业产品有限公司
  • 诺信公司
  • 杜邦公司

区域概况

Biopharmaceutical Tubing Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Biopharmaceutical Tubing Market类型
  • 塑料
  • 金属
  • 硅酮
Biopharmaceutical Tubing Market应用
  • 制药
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

生物制药管道市场驱动因素和机遇

微创手术需求增长利好市场增长

在微创医疗过程中,通常会通过切口或其他解剖开口将微型装置或植入物插入体内。这些手术越来越受欢迎,因为它们切口小,患者恢复更快,患者不适感更少。此外,这些手术还具有减轻疼痛、最小化组织损伤以及减少对肌肉、神经、组织和器官创伤等优势。

由于癌症、心脏病和关节炎的发病率不断上升,对微创手术的需求也随之增加,这些疾病都需要长时间的手术治疗。导管和生物制药管等部件的需求量很大。生物制药管系统还有助于节省时间,而且价格合理。例如,当导管用于心脏和尿液导管插入时,医疗或外科手术所需的时间会大大减少。因此,对微创医疗程序的需求不断增加,以及对提高这些程序效率的重视是推动生物制药管市场的重要因素。

发展中国家医疗保健行业的蓬勃发展和慢性病患病率的上升为市场创造了巨大的机遇

由于生活方式的显著、渐进变化,发展中国家慢性病的患病率正在上升。此外,由于采用现代工作文化和基础设施,其他健康状况(如职业病)的患病率也在上升。现代化设施导致其使用者的体力活动减少,但激烈的市场竞争也导致压力水平上升。因此,随着慢性病患病率的上升和越来越多的人寻求医疗救治,这些经济体对导管和生物制药管的需求将会增加。巴西、印度、俄罗斯、中国和南非(金砖国家)的经济体是世界上增长最快的经济体之一。人口老龄化、客户需求的变化以及对医疗保健服务意识的提高,都有望促进这些和其他发展中经济体医疗保健行业的快速扩张。由于该行业的增长,生物制药管市场预计在未来几年将具有巨大的潜力。预计政府对医疗设施的支出增加和消费者购买力的提升也将促进医疗保健行业和生物制药管道市场的发展。

生物制药管道市场报告细分分析

有助于得出生物制药管道市场分析的关键部分是类型和应用。

  • 根据类型,生物制药管市场分为塑料、金属和硅胶。硅胶部分在 2023 年占据了最大的市场份额。
  • 根据应用,市场分为制药(一次性技术及其他)、研发、医疗设备及其他。制药行业在 2023 年占据了最大的市场份额。

生物制药管道市场份额按地区分析

生物制药管道市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美洲由三个国家组成:美国、加拿大和墨西哥。在对包含导管的医疗器械不断增长的需求中,美国占有最大的份额。先进医疗器械的采用、技术进步以及向微创医疗程序的转变预计将加速生物制药导管市场的增长。此外,市场参与者正在采用有机和无机增长战略来开发市场。例如,2019 年 11 月,圣戈班生命科学公司在佛罗里达州拉哥的新工厂竣工,标志着其 7000 万欧元全球扩张计划的又一个重要里程碑,该计划将在 2020 年底前建成并投入运营七个生产基地。位于佛罗里达州拉哥的 80,000 平方英尺工厂将成为圣戈班 C-Flex 导管、模制连接和用于生物制药制造流体管理的组件的另一个生产基地。圣戈班将继续在其位于佛罗里达州克利尔沃特、法国沙尼的现有工厂生产 C-Flex 导管和相关产品线以及印度班加罗尔。

同样,2017 年 3 月,AdvantaPure 推出了 AdvantaSil 品牌的硅胶管和软管。AdvantaSil 硅胶管和软管产品适用于一次性工艺,包括增强软管、非增强管、钢丝增强抽吸软管和泵级管。这些产品专为制药和生物制药行业设计和测试。

因此,由于上述因素,预计未来几年该国的生物制药管道市场将增长

生物制药管道市场报告范围

报告属性细节
2023 年的市场规模40.4 亿美元
2031 年市场规模76.4 亿美元
全球复合年增长率(2023 - 2031)8.30%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 塑料
  • 金属
  • 硅酮
按应用
  • 制药
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 戈尔公司及其合伙人
  • 圣戈班安全材料
  • 科德宝集团
  • 瑞士劳美迪克公司
  • 技术综合公司
  • 新时代工业有限公司
  • 奥普蒂诺娃
  • 宙斯工业产品有限公司
  • 诺信公司
  • 杜邦公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

生物制药管道市场新闻和最新发展

生物制药导管市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了生物制药导管市场的一些发展情况:

  • 杜邦公司正在加快对生物制药加工行业未来的投资,扩大其有机硅弹性体和管材的供应能力,并通过新的热塑性弹性体 (TPE) 管材扩大其一次性制药产品线(来源:杜邦公司,新闻稿,2022 年 4 月)
  • Optinova 开设了 Optinova Valley Forge 工厂。新工厂是一项投资,旨在大幅提高特种工业管材解决方案的生产能力。Optinova Valley Forge 最大容量可容纳 20 多条挤出生产线,目前已建成 11 条挤出生产线。(来源:Optinova,新闻稿,2021 年 5 月)

生物制药管道市场报告覆盖范围和交付成果

“生物制药导管市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 生物制药导管市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 生物制药管道市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 生物制药管道市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及生物制药管道市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the biopharmaceutical tubing market?

The market is expected to register a CAGR of 8.30% during 2023–2031.

Which are the leading players operating in the biopharmaceutical tubing market?

W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG

What are the driving factors impacting the biopharmaceutical tubing market?

Key factors driving the market are the increasing elderly population worldwide and the rising demand for minimally invasive procedures.

What are the future trends of the biopharmaceutical tubing market?

Platinum-cured silicone as the material of choice for biopharmaceutical tubing will likely remain a key trend in the market.

Which region dominated the biopharmaceutical tubing market in 2023?

North America dominated the biopharmaceutical tubing market in 2023

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..